Trials / Completed
CompletedNCT04583787
xSPECT-based Myocardial Perfusion Scintigraphy: Consistency of Functional Values and Feasibility of Myocardial Uptake Quantitation in Patients With Suspected Coronary Artery Disease
xSPECT-based Myocardial Perfusion Scintigraphy: Consistency of Functional Values and Feasibility of Myocardial Uptake Quantitation in Patients With Suspected Coronary Artery Disease (xSPECT MPI Study)
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 52 (actual)
- Sponsor
- University Hospital, Basel, Switzerland · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study is to evaluate the feasibility of myocardial Standardized Uptake Volume (SUV) assessment by means of X- (Single photon emission tomography) SPECT/Computed tomography (CT), to assess normal reference value under rest and stress in a homogeneous population without Coronary Artery Disease (CAD) and to assess the variation of absolute quantitative SUV measurements under rest and stress. The values will be evaluated in comparison with perfusion Positron Emission Tomography (PET)/CT (using 82Rb as perfusion tracer) and CT coronary angiography (CTCA) with contrast medium.).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | 99mTc-sestamibi myocardial perfusion SPECT | 82Rb-PET/CT with CT based coronary angiography (CCTA) as part of clinical care at Day 1 |
| DIAGNOSTIC_TEST | 82Rb-Chloride myocardial perfusion PET with CCTA | stress-rest 99mTc-sestamibi myocardial perfusion SPECT, performed subsequent to 99mTc-sestamibi myocardial perfusion SPECT at Day 2 |
Timeline
- Start date
- 2021-12-07
- Primary completion
- 2024-05-28
- Completion
- 2024-05-28
- First posted
- 2020-10-12
- Last updated
- 2024-06-28
Locations
1 site across 1 country: Switzerland
Source: ClinicalTrials.gov record NCT04583787. Inclusion in this directory is not an endorsement.